Gordon C. Shore

20.3k total citations · 3 hit papers
95 papers, 8.3k citations indexed

About

Gordon C. Shore is a scholar working on Molecular Biology, Cell Biology and Epidemiology. According to data from OpenAlex, Gordon C. Shore has authored 95 papers receiving a total of 8.3k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Molecular Biology, 21 papers in Cell Biology and 18 papers in Epidemiology. Recurrent topics in Gordon C. Shore's work include Cell death mechanisms and regulation (38 papers), Mitochondrial Function and Pathology (31 papers) and ATP Synthase and ATPases Research (18 papers). Gordon C. Shore is often cited by papers focused on Cell death mechanisms and regulation (38 papers), Mitochondrial Function and Pathology (31 papers) and ATP Synthase and ATPases Research (18 papers). Gordon C. Shore collaborates with scholars based in Canada, United States and Germany. Gordon C. Shore's co-authors include Mai Nguyen, Marc Germain, David G. Breckenridge, Richard Marcellus, Ing Swie Goping, Heidi M. McBride, Feroz R. Papa, Scott A. Oakes, Anne Roulston and Matthew R. Warr and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Gordon C. Shore

95 papers receiving 8.2k citations

Hit Papers

Regulation of apoptosis by endoplasmic reticulum pathways 1998 2026 2007 2016 2003 1998 2007 200 400 600

Peers

Gordon C. Shore
A. Jennifer Rivett United Kingdom
Tomomi Kuwana United States
Bruno Antonsson Switzerland
Scott A. Oakes United States
Maria Hatzoglou United States
Solly Weiler United States
Gert Kreibich United States
Sylvie Montessuit Switzerland
Ronald Jemmerson United States
A. Jennifer Rivett United Kingdom
Gordon C. Shore
Citations per year, relative to Gordon C. Shore Gordon C. Shore (= 1×) peers A. Jennifer Rivett

Countries citing papers authored by Gordon C. Shore

Since Specialization
Citations

This map shows the geographic impact of Gordon C. Shore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gordon C. Shore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gordon C. Shore more than expected).

Fields of papers citing papers by Gordon C. Shore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gordon C. Shore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gordon C. Shore. The network helps show where Gordon C. Shore may publish in the future.

Co-authorship network of co-authors of Gordon C. Shore

This figure shows the co-authorship network connecting the top 25 collaborators of Gordon C. Shore. A scholar is included among the top collaborators of Gordon C. Shore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gordon C. Shore. Gordon C. Shore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Haipeng, Danmei Su, Jinlong Zhang, et al.. (2017). Improvement of Pharmacokinetic Profile of TRAIL via Trimer-Tag Enhances its Antitumor Activity in vivo. Scientific Reports. 7(1). 8953–8953. 68 indexed citations
2.
Prudent, Julien, Rodolfo Zunino, Ayumu Sugiura, et al.. (2015). MAPL SUMOylation of Drp1 Stabilizes an ER/Mitochondrial Platform Required for Cell Death. Molecular Cell. 59(6). 941–955. 266 indexed citations
3.
Chan, Manuel, Michel Gravel, Alexandre Bramoullé, et al.. (2014). Synergy between the NAMPT Inhibitor GMX1777(8) and Pemetrexed in Non–Small Cell Lung Cancer Cells Is Mediated by PARP Activation and Enhanced NAD Consumption. Cancer Research. 74(21). 5948–5954. 37 indexed citations
4.
Roulston, Anne, William J. Muller, & Gordon C. Shore. (2013). BIM, PUMA, and the Achilles’ Heel of Oncogene Addiction. Science Signaling. 6(268). pe12–pe12. 17 indexed citations
5.
Warr, Matthew R., John R. Mills, Mai Nguyen, et al.. (2011). Mitochondrion-dependent N-terminal Processing of Outer Membrane Mcl-1 Protein Removes an Essential Mule/Lasu1 Protein-binding Site. Journal of Biological Chemistry. 286(28). 25098–25107. 26 indexed citations
6.
Chang, Natasha C., Mai Nguyen, Marc Germain, & Gordon C. Shore. (2009). Antagonism of Beclin 1‐dependent autophagy by BCL‐2 at the endoplasmic reticulum requires NAF‐1. The EMBO Journal. 29(3). 606–618. 219 indexed citations
7.
Shore, Gordon C. & Matthew R. Warr. (2008). Unique Biology of Mcl-1: Therapeutic Opportunities in Cancer. Current Molecular Medicine. 8(2). 138–147. 158 indexed citations
8.
Wang, Bing, Donglei Zhang, Nhi Nguyen, et al.. (2008). BAP31 Interacts with Sec61 Translocons and Promotes Retrotranslocation of CFTRΔF508 via the Derlin-1 Complex. Cell. 133(6). 1080–1092. 130 indexed citations
9.
Roulston, Anne, Mark H. Watson, Cynthia Bernier, et al.. (2007). GMX1777: a novel inhibitor of NAD+ biosynthesis via inhibition of nicotinamide phosphoribosyl transferase.. Molecular Cancer Therapeutics. 6. 2 indexed citations
10.
Moldoveanu, Tudor, Qian Liu, Ante Tocilj, et al.. (2006). The X-Ray Structure of a BAK Homodimer Reveals an Inhibitory Zinc Binding Site. Molecular Cell. 24(5). 677–688. 192 indexed citations
11.
Shore, Gordon C. & Jean Viallet. (2005). Modulating the Bcl-2 Family of Apoptosis Suppressors for Potential Therapeutic Benefit in Cancer. Hematology. 2005(1). 226–230. 70 indexed citations
12.
Warr, Matthew R., Stéphane Acoca, Zhiqian Liu, et al.. (2005). BH3‐ligand regulates access of MCL‐1 to its E3 ligase. FEBS Letters. 579(25). 5603–5608. 96 indexed citations
13.
Paquet, Marie-Ève, Myrna F. Cohen-Doyle, Gordon C. Shore, & David B. Williams. (2004). Bap29/31 Influences the Intracellular Traffic of MHC Class I Molecules. The Journal of Immunology. 172(12). 7548–7555. 79 indexed citations
14.
Distelhorst, Clark & Gordon C. Shore. (2004). Bcl-2 and calcium: controversy beneath the surface. Oncogene. 23(16). 2875–2880. 89 indexed citations
15.
Breckenridge, David G., et al.. (2003). Caspase cleavage product of BAP31 induces mitochondrial fission through endoplasmic reticulum calcium signals, enhancing cytochrome c release to the cytosol. The Journal of Cell Biology. 160(7). 1115–1127. 453 indexed citations
16.
Breckenridge, David G., et al.. (2003). Regulation of apoptosis by endoplasmic reticulum pathways. Oncogene. 22(53). 8608–8618. 608 indexed citations breakdown →
17.
Chen, Gang, Philip E. Branton, Elizabeth Yang, Stanley J. Korsmeyer, & Gordon C. Shore. (1996). Adenovirus E1B 19-kDa Death Suppressor Protein Interacts with Bax but Not with Bad. Journal of Biological Chemistry. 271(39). 24221–24225. 47 indexed citations
18.
Goping, Ing Swie, Douglas G. Millar, & Gordon C. Shore. (1995). Identification of the human mitochondrial protein import receptor, huMas20p. Complementation of Δmas20 in yeast. FEBS Letters. 373(1). 45–50. 75 indexed citations
19.
Lagacé, Monique, Ing Swie Goping, Christopher R. Mueller, Maribeth A. Lazzaro, & Gordon C. Shore. (1992). The carbamyl phosphate synthetase promoter contains multiple binding sites for C/EBP-related proteins. Gene. 118(2). 231–238. 30 indexed citations
20.
Goping, Ing Swie, Monique Lagacé, & Gordon C. Shore. (1992). Factors interacting with the rat carbamyl phosphate synthetase promoter in expressing and nonexpressing tissues. Gene. 118(2). 283–287. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026